Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID‐19

More than ten million patients worldwide have been diagnosed with coronavirus disease 19 (COVID‐19) to date (WHO situation report, 1st July 2020). There is no vaccine to prevent infection with the causative organism, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), nor a cure. In the st...

Descripción completa

Detalles Bibliográficos
Autores principales: Heister, Paula M., Poston, Robin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503088/
https://www.ncbi.nlm.nih.gov/pubmed/32930523
http://dx.doi.org/10.1002/prp2.653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503088/
https://www.ncbi.nlm.nih.gov/pubmed/32930523
http://dx.doi.org/10.1002/prp2.653

Ejemplares similares